MREO vs REGN: Which Stock is Better?
Side-by-side comparison of Mereo BioPharma Group PLC ADR and Regeneron Pharmaceuticals Inc in 2026
MREO
Mereo BioPharma Group PLC ADR
$0.57
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | MREO | REGN | Winner |
|---|---|---|---|
| Market Cap | $89.93M | $77.77B | REGN |
| P/E Ratio | N/A | 17.58 | REGN |
| EPS (TTM) | $N/A | $41.75 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 73.4% | 45.8% | MREO |
Analyze MREO
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or REGN a better investment?
Comparing MREO and REGN: Mereo BioPharma Group PLC ADR has a market cap of $89.93M while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and REGN?
MREO (Mereo BioPharma Group PLC ADR) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for MREO.
Which company is more profitable: MREO or REGN?
Mereo BioPharma Group PLC ADR (MREO) has higher gross margins at 73.4% compared to 45.8% for REGN.
Which is the larger company: MREO or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $89.93M for MREO.
Should I buy MREO or REGN in 2026?
Both MREO and REGN have investment merit. MREO trades at $0.57 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and REGN stock?
Key differences: Market Cap ($89.93M vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (73.4% vs 45.8%).